drugset / Trial / NCT00345319
Purified Rabies Vaccine for Human Use (Chick-embryo Cell)
RandomizedParallel-groupSingle-blindPrevention
Summary
Evaluate the immunogenicity and safety of rabies vaccine given in a post-exposure prophylaxis regimen to healthy children and adults aged 10-60 years.
Timeline
- Start
- 2006-03
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rabies vaccine | Vaccine | — | — |